Edition:
United Kingdom

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

24.75USD
12 Dec 2017
Change (% chg)

$0.23 (+0.94%)
Prev Close
$24.52
Open
$24.53
Day's High
$24.81
Day's Low
$24.19
Volume
85,913
Avg. Vol
82,069
52-wk High
$33.10
52-wk Low
$23.04

Chart for

About

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral... (more)

Overall

Beta: 2.58
Market Cap(Mil.): $957.49
Shares Outstanding(Mil.): 33.09
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.16 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-Cardiovascular Systems Inc reports Q1 loss per share $0.06

* Cardiovascular Systems Inc reports fiscal 2018 first-quarter financial results

25 Oct 2017

BRIEF-Cardiovascular Systems announces anticipated revenue impact from hurricanes

* Cardiovascular Systems announces anticipated revenue impact from hurricanes Harvey and Irma

18 Sep 2017

BRIEF-Cardiovascular Systems Q4 earnings per share $0.02

* Cardiovascular Systems, Inc. Reports fiscal 2017 fourth-quarter financial results

02 Aug 2017

BRIEF-Brown Capital Management LLC reports 7.56 pct passive stake in Cardiovascular Systems

* Brown Capital Management LLC reports 7.56 percent passive stake in Cardiovascular Systems Inc as of June 30 - sec filing Source text : http://bit.ly/2u638Ru Further company coverage:

10 Jul 2017

BRIEF-Cardiovascular Systems says on June 27, Plaintiffs filed an amended complaint regarding Shoemaker V. Cardiovascular Systems case

* Cardiovascular Systems - On June 27, 2017, Plaintiffs filed an amended complaint regarding Shoemaker V. Cardiovascular Systems case

29 Jun 2017

Earnings vs. Estimates